P907: CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB (KDD) VS CARFILZOMIB AND DEXAMETHASONE (KD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): FRAILTY SUBGROUP ANALYSIS OF THE CANDOR STUDY. (23rd June 2022) - Quach, H.; Leleu, X.; Mateos, M.-V.; Usmani, S. Z.; Nooka, A. K.; Goldrick, A.; Najdi, R.; Shu, N.; Facon, T.